首页> 外文期刊>Genetic Engineering & Biotechnology News: The Information Source of the Biotechnology Industry >Diagnostics Advancing Healthcare Reform: Molecular-Based Technologies for Diagnosis and Prognosis Could Reduce Costs
【24h】

Diagnostics Advancing Healthcare Reform: Molecular-Based Technologies for Diagnosis and Prognosis Could Reduce Costs

机译:诊断推动医疗改革:基于分子的诊断和预后技术可以降低成本

获取原文
获取原文并翻译 | 示例
       

摘要

With the presidential elections around the corner, healthcare reform was a hot topic at the "JP Morgan 26th Annual Healthcare Conference," held in January. For biotech executives, it was music to their ears to hear presidential candidates speak abouttheir intentions to have the federal government invest in novel technologies that could change the sharp, upward trajectory in healthcare costs.
机译:随着即将举行的总统大选,医疗改革成为1月举行的“ JP Morgan第26届年度医疗会议”的热门话题。对于生物技术公司的高管来说,听到总统候选人谈论他们希望联邦政府投资可能改变医疗保健费用急剧上升趋势的新技术的意图,是耳听不绝的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号